epub | 1.24 MB | English | Isbn: B099KP24ZW | Author: Peter Loftus | Year: 2022
Description:
Alıntı:
The inside story of an unprecedented feat of science and business. At the start of 2020, Moderna was a biotech unicorn with dim prospects. Yes, there was the promise of its disruptive innovation that could transform medicine by using something called messenger RNA, one of the body's building blocks of life, to combat disease. But its stock was under water. There were reports of a toxic work culture. And despite ten years of work, the company was still years away from delivering its first product. Investors were getting antsy, or worse, skeptical. Then the pandemic hit, and Moderna, at first reluctantly, became a central player in a global drama-a David to Big Pharma's Goliaths-turning its technology toward breaking the global grip of the terrible disease. By year's end, with the virus raging, Moderna delivered one of the world's first Covid-19 vaccines, with a stunningly high rate of protection. The achievement gave the world a way out of a...
|
Category:Pharmaceutical & Biotechnology Industry, Business Research & Development, Pharmaceutical & Biotechnology Industry
Kod:
https://rapidgator.net/file/5cb1eff37660ae571f383e63da84a0e1/
Kod:
https://filerice.com/3zjepfjnptk5